Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents.

Pamukcu B., Huber K., Lip G.

Current pharmaceutical design, cilt.18, ss.850-60, 2012 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 18
• Basım Tarihi: 2012
• Doi Numarası: 10.2174/138161212799277716
• Dergi Adı: Current pharmaceutical design
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.850-60
• Anahtar Kelimeler: Atherothrombosis, cardiovascular disease, primary prevention, secondary prevention, novel antithrombotics, PERCUTANEOUS CORONARY INTERVENTION, VON-WILLEBRAND-FACTOR, OPTIMIZING PLATELET INHIBITION, THROMBIN-RECEPTOR ANTAGONIST, ACUTE MYOCARDIAL-INFARCTION, LOW-DOSE ASPIRIN, APTAMER ARC1779, DOUBLE-BLIND, P2Y(12) ANTAGONIST, ASSESS IMPROVEMENT
• Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır